Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.

Area of Science:

• Cardiovascular Research
• Pharmacology
• Critical Care Medicine

Background:

• Sodium-hydrogen exchanger isoform-1 (NHE-1) activation exacerbates myocardial dysfunction during ischemia and reperfusion.
• NHE-1 activity is hypothesized to limit the success of cardiac resuscitation from ventricular fibrillation (VF).

Purpose of the Study:

• To investigate if cariporide, an NHE-1 inhibitor, could improve resuscitability, post-resuscitation myocardial function, and survival in VF models.
• To evaluate the efficacy of NHE-1 inhibition in both isolated and intact rat hearts during VF resuscitation.

Main Methods:

• Ventricular fibrillation (VF) was induced in isolated rat hearts and intact rats.
• Cariporide was administered to assess its effects on ischemic contracture, diastolic dysfunction, and return of contractile function.
• In intact rats, spontaneous defibrillation rates and post-resuscitation hemodynamic function were compared between cariporide-treated and control groups.

Main Results:

• Cariporide ameliorated ischemic contracture and prevented post-resuscitation diastolic dysfunction in isolated hearts.
• In intact rats, cariporide prompted spontaneous defibrillation in 6 of 8 rats, whereas controls required electrical defibrillation.
• Cariporide-treated rats exhibited reduced ventricular ectopic activity and faster hemodynamic recovery post-resuscitation.

Conclusions:

• NHE-1 inhibition with cariporide significantly improves cardiac resuscitation outcomes from VF.
• Cariporide demonstrates potential as a novel and effective therapeutic intervention for VF resuscitation.
• The benefits of cariporide were more pronounced under conditions of severe ischemia.